{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:35:41Z","timestamp":1791081341028,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1894,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/mt.2011.61","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T12:27:22Z","timestamp":1302092842000},"page":"1511-1520","source":"Crossref","is-referenced-by-count":42,"title":["In Vivo Expansion of Regulatory T cells With IL-2\/IL-2 mAb Complexes Prevents Anti-factor VIII Immune Responses in Hemophilia A Mice Treated With Factor VIII Plasmid-mediated Gene Therapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Chao-Lien","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol H","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.61_bib1","first-page":"81","article-title":"Molecular genetics of hemophilia A in man (factor VIII deficiency)","volume":"4","author":"Antonarakis","year":"1987","journal-title":"Mol Biol Med"},{"key":"10.1038\/mt.2011.61_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-009-8122-5","article-title":"Factor VIII inhibitors: risk factors and methods for prevention and immune modulation","volume":"37","author":"Zhang","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1038\/mt.2011.61_bib3","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1073\/pnas.96.18.10379","article-title":"Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice","volume":"96","author":"VandenDriessche","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.61_bib4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2003-01-0167","article-title":"Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion","volume":"102","author":"Powell","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2011.61_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymthe.2004.04.009","article-title":"Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice","volume":"10","author":"Ye","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.61_bib6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ymthe.2005.09.007","article-title":"Correction of murine hemophilia A by hematopoietic stem cell gene therapy","volume":"12","author":"Moayeri","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.61_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2005-12-5115","article-title":"Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2011.61_bib8","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1538-7836.2006.01901.x","article-title":"Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model","volume":"4","author":"McCormack","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1038\/mt.2011.61_bib9","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1538-7836.2009.03538.x","article-title":"The molecular mechanisms of immunomodulation and tolerance induction to factor VIII","volume":"7","author":"Waters","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1038\/mt.2011.61_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/156652307782151524","article-title":"Recent advances in immune modulation","volume":"7","author":"Miao","year":"2007","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2011.61_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2004-825635","article-title":"Immune implications of gene therapy for hemophilia","volume":"30","author":"Herzog","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1038\/mt.2011.61_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1038\/mt.2011.61_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nri2189","article-title":"Regulatory T cells and infection: a dangerous necessity","volume":"7","author":"Belkaid","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/mt.2011.61_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri1589","article-title":"Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma","volume":"5","author":"Hawrylowicz","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/mt.2011.61_bib15","first-page":"269","article-title":"IL-10-producing type 1 regulatory T cells and allergy","volume":"4","author":"Wu","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"10.1038\/mt.2011.61_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0105-2896.2006.00415.x","article-title":"The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells","volume":"212","author":"Shevach","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1038\/mt.2011.61_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.0105-2896.2006.00423.x","article-title":"Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation","volume":"212","author":"Izcue","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1038\/mt.2011.61_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.0105-2896.2006.00409.x","article-title":"Natural regulatory T cells and parasites: a common quest for host homeostasis","volume":"212","author":"Belkaid","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1038\/mt.2011.61_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.0105-2896.2006.00412.x","article-title":"Regulatory T cells in virus infections","volume":"212","author":"Rouse","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1038\/mt.2011.61_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"Aluvihare","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1038\/mt.2011.61_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","article-title":"Regulatory T cells in cancer","volume":"108","author":"Beyer","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2011.61_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/ehm.10.33","article-title":"Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells","volume":"3","author":"Miao","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1038\/mt.2011.61_bib23","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood-2009-06-228155","article-title":"CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice","volume":"114","author":"Miao","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2011.61_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.194.5.591","article-title":"T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors","volume":"194","author":"Almeida","year":"2001","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2011.61_bib25","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.4049\/jimmunol.173.12.7259","article-title":"CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion","volume":"173","author":"Curotto de Lafaille","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/mt.2011.61_bib26","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"10.1038\/mt.2011.61_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20082824","article-title":"In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression","volume":"206","author":"Webster","year":"2009","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2011.61_bib28","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/eji.200939792","article-title":"Expansion of regulatory T cells via IL-2\/anti-IL-2 mAb complexes suppresses experimental myasthenia","volume":"40","author":"Liu","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2011.61_bib29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/14712598.6.12.1323","article-title":"Potential use of IL-2\/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease","volume":"6","author":"Boyman","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/mt.2011.61_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","article-title":"Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction","volume":"28","author":"Tang","year":"2008","journal-title":"Immunity"},{"key":"10.1038\/mt.2011.61_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4049\/jimmunol.177.1.306","article-title":"IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb","volume":"177","author":"Kamimura","year":"2006","journal-title":"J Immunol"},{"key":"10.1038\/mt.2011.61_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2005-11-4532","article-title":"Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice","volume":"108","author":"Miao","year":"2006","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1038\/mt.2011.61_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1538-7836.2009.03417.x","article-title":"Role of regulatory T cells in tolerance to coagulation factors","volume":"7","author":"Cao","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1038\/mt.2011.61_bib34","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2008-01-128413","article-title":"Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice","volume":"112","author":"Peng","year":"2008","journal-title":"Blood"},{"key":"10.1038\/mt.2011.61_bib35","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.158.6.1895","article-title":"Transient expression of interleukin 2 receptors. Consequences for T cell growth","volume":"158","author":"Cantrell","year":"1983","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2011.61_bib36","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.6427923","article-title":"The interleukin-2 T-cell system: a new cell growth model","volume":"224","author":"Cantrell","year":"1984","journal-title":"Science"},{"key":"10.1038\/mt.2011.61_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0092-8674(93)90152-G","article-title":"The IL-2\/IL-2 receptor system: a current overview","volume":"73","author":"Taniguchi","year":"1993","journal-title":"Cell"},{"key":"10.1038\/mt.2011.61_bib38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2011.61_bib39","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/ni1264","article-title":"Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling","volume":"6","author":"D'Cruz","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1038\/mt.2011.61_bib40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1038\/mt.2011.61_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2010.02.009","article-title":"Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties","volume":"32","author":"Ponpuak","year":"2010","journal-title":"Immunity"},{"key":"10.1038\/mt.2011.61_bib42","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1073\/pnas.0501701102","article-title":"Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter","volume":"102","author":"Wan","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.61_bib43","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4049\/jimmunol.151.3.1235","article-title":"Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes","volume":"151","author":"Finkelman","year":"1993","journal-title":"J Immunol"},{"key":"10.1038\/mt.2011.61_bib44","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1073\/pnas.0909384107","article-title":"IL-2\/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25","volume":"107","author":"L\u00e9tourneau","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.61_bib45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2011.61_bib46","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1182\/blood-2009-05-217315","article-title":"Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy","volume":"114","author":"Peng","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2011.61_bib47","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1182\/blood.V88.9.3446.bloodjournal8893446","article-title":"Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies","volume":"88","author":"Bi","year":"1996","journal-title":"Blood"},{"key":"10.1038\/mt.2011.61_bib48","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/104303403322319381","article-title":"High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors","volume":"14","author":"Miao","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2011.61_bib49","first-page":"612","article-title":"Proceedings: A more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1038\/mt.2011.61_bib50","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nm924","article-title":"TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes","volume":"9","author":"Belghith","year":"2003","journal-title":"Nat Med"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616325205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616325205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T03:55:41Z","timestamp":1686023741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616325205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1525001616325205"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.61","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}